Non-invasive measurement of blood glucose
CA 2086019 C · Owner: Paynter, Lynn N. · Inventors: Mackie, Linda H.; Rosenthal, Robert D.; Paynter, Lynn N.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Near-infrared quantitative analysis instruments (170) non-invasively measure blood glucose by analyzing near-infrared energy following interactance with venous or arterial blood or, transmission through a blood containing body part. A replaceable cartridge (195) stores data unique to an individual patient/user. The analysis instruments (170) are accurate and readily lend themselves to at-home testidiabetics. A method is also disclosed for easily and reliably custom calibrating near-infrared quantitative analysis instruments including obtaining a plurality of blood samples and blood glucose level measurements thereof at a predetermined time interval. These values are entered into the …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 27, 1991 and granted September 8, 1998. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended June 27, 2011.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 27, 2013.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.